Clinical Evidence for the Role of Trichomonas vaginalis in Regulation of Secretory Leukocyte Protease Inhibitor in the Female Genital Tract | Zendy

Jill S. Huppert | Zendy; Bin Huang | Zendy; Chen Chen | Zendy; Hassan Y. Dawood | Zendy; Rai. Fichorova | Zendy

Open Access

Clinical Evidence for the Role of Trichomonas vaginalis in Regulation of Secretory Leukocyte Protease Inhibitor in the Female Genital Tract

Author(s) -

Jill S. Huppert,

Bin Huang,

Chen Chen,

Hassan Y. Dawood,

Rai. Fichorova

Publication year - 2013

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jit039

Subject(s) - trichomonas vaginalis , genital tract , trichomonas , microbiology and biotechnology , protease inhibitor (pharmacology) , immunology , protease , biology , trichomonas vaginitis , female circumcision , medicine , physiology , enzyme , gynecology , virus , biochemistry , antiretroviral therapy , viral load

Secretory leukocyte protease inhibitor (SLPI) is responsible for regulating inflammatory damage to and innate and adaptive immune responses in the vaginal mucosa. Depressed cervicovaginal SLPI levels have been correlated with both Trichomonas vaginalis infection and poor reproductive health outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research